LOGIN
Similar Outcomes With Native Vitamin D and Eldecalcitol in Osteoporotic Women Taking Denosumab
November 2020
Similar Outcomes With Native Vitamin D and Eldecalcitol in Osteoporotic Women Taking Denosumab
Study Type:Therapy
OE Level Evidence:1
Journal Level of Evidence:1
Comparison of the Effects of Native Vitamin D and Eldecalcitol on Muscular Strength and Dynamic Balance in Patients with Postmenopausal Osteoporosis.
Prog Rehabil Med . 2020 Oct 30;5:20200026Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
Synopsis
Thirty postmenopausal women with osteoporosis receiving denosumab treatment were randomized to receive either native vitamin D plus calcium supplementation or active Vitamin D3 (eldecalcitol). The outcomes of interest included muscle strength, static and dynamic postural balance, sitting balance, serum biochemical analyses (e.g. 25 hydroxyvitamin D, calcium, phosphorous, creatinine, blood urea nit...
To view the full content, login to your account,
or start your 30-day FREE Trial today.
FREE TRIAL
LOGIN
Forgot Password?
Explore some of our unlocked ACE Reports below!
Learn about our AI Driven
High Impact Search Feature
The OE High Impact metric uses AI to determine the impact a study will have by considering the content of the article itself. Built using the latest advances of natural language processing techniques. OE High Impact predicts an article’s future number of citations than impact factor alone.
Continue
Join the Conversation
Please Login or Join to leave comments.